Comparative Effectiveness and Cost-Benefit Analysis of Vancomycin Powder in High Risk Spine Surgery Patients

NCT01566422 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped unable to enroll any participants

Conditions

Surgical Site Infection

Interventions

DRUG: Vancomycin powder

Sponsor

Vanderbilt University Medical Center